The scientific committee invites speakers to submit their abstracts on the below key topics.- Advances in heart failure prevention
- State-of-the-Art reviews: Heart failure with reduced ejection fraction incorporating the latest approved therapies for heart failure; Heart failure with preserved ejection fraction; and newly approved device therapies for heart failure
- An update on percutaneous treatment of valvular heart disease
- A glimpse of future therapies including gene therapy for heart failure
- Coronary artery diseases
- Dyslipidemia
- Myocardial infarction
- Hypertension complications
- Diabetes and metabolic syndrome
- Heart failure imaging
- Biomarkers
- Renal dysfunction
- Lipid disorders
- Overweight/Obesity
- Novel heart failure therapies
- Cardiogenic shock: how can we improve prognosis?
- Individualizing therapy in heart failure
- Devices in acute heart failure
- How to manage acute right ventricular failure
- Challenges in the management of heart failure
- Cancer and heart failure
- Organ dysfunction in acute heart failure
- Management of atrial fibrillation in heart failure
- Imaging technique in the decision making of heart failure
- Post myocardial infarction: what should be done to prevent heart failure
- Challenging clinical scenarios in heart failure
- Tele-medical management and remote care in heart failure
- What a clinician should know about heart failure with preserved ejection fraction
- Biomarkers in heart failure: what’s new?
- Mitral and Tricuspid valvular interventions in heart failure
- Cardiomyopathies: what are the mechanisms?
- Sleep breathing disorders in heart failure
- Imaging in heart failure: what does the future hold?
- Cardiac challenges during pregnancy
- Patient journey in acute heart failure
Abstract GuidelinesAbstracts must contain original scientific data collected by the author(s). All reports must be based on work that has already been completed. No studies "in progress" will be accepted. Any established research design or method may be used. The abstracts will be scored on the following criteria:
- Originality
- Concept and design
- Presentation
- Clinical applicability
- Other characteristics
Language: All abstracts are to be written in English. The Scientific Committee reserves the right to edit abstracts for grammar and clarity.
Submission: All abstracts must be submitted via the Abstract Form which can be accessed at www.menaconference.com this should be limited to a maximum of 250 words and should include the following:
Title of abstractNames and contact details of author(s) {organization, city /country, email, phone numbers, fax numbers and mailing address}. Please indicate the name of the presenter/ clearly and provide the author’s biography with the abstract.
The abstract must include the following headings clearly: Purpose, Methods, Results and Conclusions.
Abstract submission will be acknowledged via email. If you do not receive an email within one week of submission or have any additional queries please contact Ms. Andra Mae, email: andra.mae@menaconference.com
Important dates
- 30th July, 2016 – Deadline for submission of abstracts.
- 15th August, 2016 – Presenters will be notified of acceptance.
Important Information- All abstracts must be prepared using the abstract submission guidelines.
- Each presenter may submit a maximum of two abstracts.
- Each abstract submission must indicate if the material was published or presented in any prior Congress or if it received any awards
- All presenters will be registered to attend the Conference if abstract is accepted and be present at the time of the Congress.
- A certificate of appreciation will be given to all the presenters to honor their presentation.
- Presenters must not use the session as a marketing opportunity for products/equipment
- Travel (Economy class ticket), accommodation and visa process will be provided to accepted abstracts
WE LOOK FORWARD TO RECEIVING YOUR ABSTRACTS!
Attach Abstract Presentation
Allowed file formats : Pdf .doc . Docx only
* Fields are mandatory.
